Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study
Margaret C. Fang(San Francisco General Hospital), Daniel E. Singer(Kaiser Permanente), Lori Henault(Kaiser Permanente), Elaine M. Hylek(Boston University), Nancy G. Jensvold(Kaiser Permanente), Yuchiao Chang(Harvard University), Alan S. Go(Kaiser Permanente)
Cited by 250
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
Heart Disease and Stroke Statistics—2013 Update
|Circulation|2012|5.2k